Pharmacological study of 2-phosphonoxybenzoic acid (fosfosal), a new analgesic drug.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D006461:Hemolysis / Q000187:drug effects; D008297:Male; D051379:Mice; D010755:Organophosphates / Q000494:pharmacology*; D009943:Organophosphorus Compounds / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000096:biosynthesis; D051381:Rats; D012459:Salicylates / Q000494:pharmacology*; D013276:Stomach Ulcer / Q000139:chemically induced
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D010755:Organophosphates; D009943:Organophosphorus Compounds; D011453:Prostaglandins; D012459:Salicylates; C000380:fosfosal; D015105:3',5'-Cyclic-AMP Phosphodiesterases